Search
for
Sort by
Research 361–390 of 560
- Skin Structure, Physiology, and Pathology in Topical and Transdermal Drug Delivery
- Deciphering the Complex Immunopathogenesis of Alopecia Areata
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- Hydrogel-Forming Microneedles in the Management of Dermal Disorders Through a Non-Invasive Process: A Review
- Advances in Digital Light Processing (DLP) Bioprinting: A Review of Biomaterials and Its Applications, Innovations, Challenges, and Future Perspectives
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Swellable Microneedles in Drug Delivery and Diagnostics
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Advances in medical polyesters for vascular tissue engineering
- Polyhydroxyalkanoates: Medical Applications and Potential for Use in Dentistry
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Research Progress of Sodium Alginate-Based Hydrogels in Biomedical Engineering
- Advances in Research of Hydrogel Microneedle-Based Delivery Systems for Disease Treatment
- SIRT1 downregulation provokes immune-inflammatory responses in hair follicle outer root sheath cells and may contribute to development of alopecia areata
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Clindamycin-Loaded Polyhydroxyalkanoate Nanoparticles for the Treatment of Methicillin-Resistant Staphylococcus aureus-Infected Wounds
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Mechanisms of autophagy and their implications in dermatological disorders
- Baricitinib for the Treatment of Alopecia Areata
- Immune therapies for alopecia areata: evidence and new perspectives
- Comparison of efficacy and safety of tofacitinib and azathioprine in patients with alopecia areata and variants: a double-blind, randomized controlled trial
- Alopecia areata
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- Single-cell analysis of temporal immune cell dynamics in alopecia areata reveals a causal role for clonally expanded CD8+ T cells in disease
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- A Threefold Association Between Vitiligo and Alopecia Areata: Results from a Nationwide Case-control Observational Study
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients